{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:39:52Z","timestamp":1792633192226,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":259,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2020]]},"DOI":"10.1016\/j.idcr.2020.e00961","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T13:06:22Z","timestamp":1600347982000},"page":"e00961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Increased risk of disseminated cryptococcal infection in a patient with multiple sclerosis on fingolimod"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8711-3574","authenticated-orcid":false,"given":"Pushpinder","family":"Kaur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolas St","family":"Cyr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaman","family":"Muhammad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2020.e00961_bib0005","series-title":"Lancet","first-page":"1221","article-title":"Multiple sclerosis","author":"Compston","year":"2002"},{"key":"10.1016\/j.idcr.2020.e00961_bib0010","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/DHPS.S69640","article-title":"Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis","volume":"7","author":"Gajofatto","year":"2015","journal-title":"Drug Healthc Patient Saf"},{"issue":"6","key":"10.1016\/j.idcr.2020.e00961_bib0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S1474-4422(14)70049-3","article-title":"Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"13","author":"Calabresi","year":"2014","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.idcr.2020.e00961_bib0020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1080\/21505594.2019.1614383","article-title":"Basic principles of the virulence of Cryptococcus","volume":"10","author":"Zaragoza","year":"2019","journal-title":"Virulence [Internet]"},{"issue":"October (4)","key":"10.1016\/j.idcr.2020.e00961_bib0025","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.4049\/jimmunol.129.4.1675","article-title":"The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages","volume":"129","author":"Kozel","year":"1982","journal-title":"J Immunol [Internet]"},{"issue":"6","key":"10.1016\/j.idcr.2020.e00961_bib0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7224\/1537-2073.2018-080","article-title":"Fingolimod and cryptococcosis: collision of immunomodulation with infectious disease","volume":"21","author":"Samudralwar","year":"2019","journal-title":"Int J MS Care"},{"key":"10.1016\/j.idcr.2020.e00961_bib0035","first-page":"355","volume":"Vol. 73","author":"Forrestel","year":"2016"},{"issue":"2","key":"10.1016\/j.idcr.2020.e00961_bib0040","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/1352458516670732","article-title":"Cutaneous cryptococcosis in a patient taking fingolimod for multiple sclerosis: here come the opportunistic infections?","volume":"23","author":"Carpenter","year":"2020","journal-title":"Mult Scler [Internet]"},{"key":"10.1016\/j.idcr.2020.e00961_bib0045","first-page":"1203","volume":"Vol. 72","author":"Achtnichts","year":"2015"},{"key":"10.1016\/j.idcr.2020.e00961_bib0050","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.msard.2016.07.015","article-title":"Immunologic mechanisms of fingolimod and the role of immunosenescence in the risk of cryptococcal infection: a case report and review of literature","volume":"9","author":"Grebenciucova","year":"2016","journal-title":"Mult Scler Relat Disord [Internet]"},{"issue":"September 2015","key":"10.1016\/j.idcr.2020.e00961_bib0055","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.msard.2016.06.007","article-title":"Cryptococcal meningitis after fingolimod discontinuation in a patient with multiple sclerosis","volume":"9","author":"Ward","year":"2016","journal-title":"Mult Scler Relat Disord [Internet]"},{"key":"10.1016\/j.idcr.2020.e00961_bib0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bcr-2017-220026","article-title":"Cryptococcal meningitis causing obstructive hydrocephalus in a patient on fingolimod","volume":"2017","author":"Pham","year":"2017","journal-title":"BMJ Case Rep"},{"issue":"November 53\u20136","key":"10.1016\/j.idcr.2020.e00961_bib0065","article-title":"Cryptococcal meningitis in a multiple sclerosis patient treated with Fingolimod: a case report and review of imaging findings","volume":"54","author":"Chong","year":"2019","journal-title":"Clin Imaging [Internet]"},{"issue":"May 2017","key":"10.1016\/j.idcr.2020.e00961_bib0070","first-page":"8","article-title":"Refractory cryptococcal meningoencephalitis in a patient with multiple sclerosis treated with fingolimod: a case report","volume":"12","author":"Anene-Maidoh","year":"2018","journal-title":"Interdiscip Neurosurg Adv Tech Case Manag [Internet]"},{"issue":"August 2019","key":"10.1016\/j.idcr.2020.e00961_bib0075","article-title":"Cryptococcus neoformans var grubii meningoencephalitis in a patient on fingolimod for relapsing-remitting multiple sclerosis: case report and review of published cases","volume":"39","author":"Ma","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.idcr.2020.e00961_bib0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12883-020-01741-0","article-title":"Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - Case report","volume":"20","author":"Wienemann","year":"2020","journal-title":"BMC Neurol"},{"key":"10.1016\/j.idcr.2020.e00961_bib0085","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.0000000000001929","article-title":"Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod","volume":"85","author":"Huang","year":"2015","journal-title":"Neurology"},{"issue":"22","key":"10.1016\/j.idcr.2020.e00961_bib0090","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.2169\/internalmedicine.55.7255","article-title":"Disseminated cryptococcosis in a 63-year-old patient with multiple sclerosis treated with fingolimod","volume":"55","author":"Seto","year":"2016","journal-title":"Intern Med"},{"key":"10.1016\/j.idcr.2020.e00961_bib0095","series-title":"Paradoxical immune responses in Non-HIV cryptococcal meningitis","first-page":"1","author":"Panackal","year":"2015"},{"issue":"1","key":"10.1016\/j.idcr.2020.e00961_bib0100","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1007\/978-3-540-75387-2_123","article-title":"Cryptococcosis","volume":"30","author":"Curi","year":"2016","journal-title":"Intraocular Inflamm"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250920302699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250920302699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:03:36Z","timestamp":1761998616000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250920302699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"references-count":20,"alternative-id":["S2214250920302699"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2020.e00961","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased risk of disseminated cryptococcal infection in a patient with multiple sclerosis on fingolimod","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2020.e00961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e00961"}}